Suppr超能文献

电压门控钙通道的α2δ1 亚基可作为乳腺癌肿瘤起始细胞的潜在候选生物标志物。

The α2δ1 subunit of the voltage-gated calcium channel acts as a potential candidate for breast cancer tumor initial cells biomarker.

出版信息

Cancer Biomark. 2021;31(3):295-305. doi: 10.3233/CBM-203165.

Abstract

BACKGROUND

The voltage-gated calcium channel subunit alpha 2 delta 1 (α2δ1) is a functional tumor initial cells (TICs) marker for some solid cancer cells. This study aimed to investigate whether α2δ1 can be used as a potential TIC marker for breast cancer cells.

METHODS

α2δ1+ and α2δ1- cells were identified and sorted from the breast cancer cell lines MDA-MB-231, MDA-MB-435s and ZR-75-1 by Immunofluorescence (IF) and Fluorescent-activated cell sorting (FACS) analyses. Spheroid formation in vitro and tumorigenesis in NOD/SCID mice were assessed to determine the self-renewal and serial transplantation abilities of these cells. Using a lentivirus infection system for α2δ1 in breast cancer cell lines, we determined the mRNA levels of stemnessassociated genes by quality real-time PCR (qRT-PCR). Boyden chamber and wounding assays were further performed to detect the migration of α2δ1 overexpression cells. Bioinformatics explored the relationship of molecular classification of breast cancer and drug resistance.

RESULTS

α2δ1 presents on the cytomembrane of breast cancer cells, with a positive rate of 1.5-3%. The α2δ1+ cells in breast cancer cell lines have a stronger self-renewal ability and tumor initiating properties in vitro and in vivo. Overexpressing α2δ1 successfully enhanced the sphere-forming efficiency, and upregulated the expression of stemness-associated genes, and increased cell migration. However, seldom significant was available between estrogen receptor +/- (ER+/-), progesterone receptor (PR+/-), and Her2+/-.

CONCLUSIONS

Breast cancer cells positive for the α2δ1 charactered tumor initiation, and α2δ1 is a potential TIC marker for breast cancer that further promotes the migration.

摘要

背景

电压门控钙通道亚基α2δ1(α2δ1)是某些实体癌细胞中的功能肿瘤起始细胞(TICs)标志物。本研究旨在探讨α2δ1是否可作为乳腺癌细胞的潜在 TIC 标志物。

方法

通过免疫荧光(IF)和荧光激活细胞分选(FACS)分析,从乳腺癌细胞系 MDA-MB-231、MDA-MB-435s 和 ZR-75-1 中鉴定和分选出α2δ1+和α2δ1-细胞。体外球体形成和 NOD/SCID 小鼠肿瘤发生用于评估这些细胞的自我更新和连续移植能力。使用慢病毒感染系统在乳腺癌细胞系中感染α2δ1,通过质量实时 PCR(qRT-PCR)确定干性相关基因的 mRNA 水平。进一步进行 Boyden 室和划痕实验,以检测α2δ1过表达细胞的迁移。生物信息学探索了乳腺癌的分子分类与耐药性之间的关系。

结果

α2δ1 存在于乳腺癌细胞的细胞质膜上,阳性率为 1.5-3%。乳腺癌细胞系中的α2δ1+细胞具有更强的体外和体内自我更新能力和肿瘤起始特性。过表达α2δ1成功提高了球体形成效率,并上调了干性相关基因的表达,增加了细胞迁移。然而,在雌激素受体+/-(ER+/-)、孕激素受体(PR+/-)和 Her2+/-之间,很少有显著差异。

结论

α2δ1 阳性的乳腺癌细胞具有肿瘤起始特性,α2δ1 是乳腺癌的潜在 TIC 标志物,进一步促进了迁移。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验